After finishing at $21.80 in the prior trading day, Constellium SE (NYSE: CSTM) closed at $21.67, down -0.60%. In other words, the price has decreased by -$0.13 from its previous closing price. On the day, 554126 shares were traded.
Ratios:
Our goal is to gain a better understanding of CSTM by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.01 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 17.20. For the most recent quarter (mrq), Quick Ratio is recorded 0.52 and its Current Ratio is at 1.31. In the meantime, Its Debt-to-Equity ratio is 2.22 whereas as Long-Term Debt/Eq ratio is at 2.15.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on January 16, 2024, initiated with a Buy rating and assigned the stock a target price of $27.
On May 08, 2023, JP Morgan started tracking the stock assigning a Overweight rating and target price of $24.
JP Morgan Downgraded its Overweight to Neutral on December 10, 2021, whereas the target price for the stock was revised from $22 to $21.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CSTM now has a Market Capitalization of 3.18B and an Enterprise Value of 4.98B. As of this moment, Constellium’s Price-to-Earnings (P/E) ratio for their current fiscal year is 23.72, and their Forward P/E ratio for the next fiscal year is 8.88. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.40 while its Price-to-Book (P/B) ratio in mrq is 3.42. Its current Enterprise Value per Revenue stands at 0.69 whereas that against EBITDA is 8.23.
Stock Price History:
Over the past 52 weeks, CSTM has reached a high of $23.20, while it has fallen to a 52-week low of $13.40. The 50-Day Moving Average of the stock is 20.16, while the 200-Day Moving Average is calculated to be 18.32.
Shares Statistics:
The stock has traded on average 696.51K shares per day over the past 3-months and 705.52k shares per day over the last 10 days, according to various share statistics. A total of 146.82M shares are outstanding, with a floating share count of 125.75M. Insiders hold about 12.86% of the company’s shares, while institutions hold 81.82% stake in the company. Shares short for CSTM as of Mar 15, 2024 were 1.74M with a Short Ratio of 2.65, compared to 1.55M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.18% and a Short% of Float of 1.76%.
Earnings Estimates
Its stock is currently analyzed by 4 different market analysts. On average, analysts expect EPS of $0.31 for the current quarter, with a high estimate of $0.41 and a low estimate of $0.22, while EPS last year was $0.15. The consensus estimate for the next quarter is $0.6, with high estimates of $0.72 and low estimates of $0.49.
Analysts are recommending an EPS of between $2.43 and $1.82 for the fiscal current year, implying an average EPS of $2.03. EPS for the following year is $2.47, with 4 analysts recommending between $2.78 and $2.26.
Revenue Estimates
4 analysts predict $1.8B in revenue for the current quarter. It ranges from a high estimate of $1.91B to a low estimate of $1.71B. As of the current estimate, Constellium SE’s year-ago sales were $1.99B, an estimated decrease of -9.30% from the year-ago figure.
A total of 4 analysts have provided revenue estimates for CSTM’s current fiscal year. The highest revenue estimate was $8.11B, while the lowest revenue estimate was $7.49B, resulting in an average revenue estimate of $7.79B. In the same quarter a year ago, actual revenue was $7.86B, down -1.00% from the average estimate. Based on 4 analysts’ estimates, the company’s revenue will be $8.5B in the next fiscal year. The high estimate is $9.36B and the low estimate is $7.9B. The average revenue growth estimate for next year is up 9.10% from the average revenue estimate for this year.
